ALG13 and glioblastoma: Zhao et al. demonstrated that the ALG13 UDP-N-acetylglucosaminyltransferase subunit gene was dysregulated in GBM, involved in the progression of GBM, and associated with secondary temozolomide-resistance according to microarray data analysis [7].